POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 117 filers reported holding POINT BIOPHARMA GLOBAL INC in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $949 | -9.0% | 142,257 | +23.5% | 0.00% | 0.0% |
| Q2 2023 | $1,043 | +41.9% | 115,227 | +14.1% | 0.00% | – |
| Q1 2023 | $735 | -43.5% | 100,958 | -43.4% | 0.00% | -100.0% |
| Q4 2022 | $1,301 | -99.8% | 178,498 | +88.3% | 0.00% | 0.0% |
| Q3 2022 | $733,000 | +531.9% | 94,803 | +453.5% | 0.00% | – |
| Q2 2022 | $116,000 | +7.4% | 17,129 | +26.2% | 0.00% | – |
| Q1 2022 | $108,000 | – | 13,578 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,383,029 | $24,594,621 | 4.83% |
| Velan Capital Investment Management LP | 494,136 | $3,592,369 | 3.06% |
| BVF INC/IL | 10,563,748 | $76,798,448 | 2.81% |
| JOHNSON & JOHNSON | 1,000,000 | $7,270,000 | 2.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 952,642 | $6,925,707 | 1.16% |
| PFM Health Sciences, LP | 3,204,790 | $23,298,823 | 1.03% |
| Pier Capital, LLC | 862,736 | $6,272,091 | 0.95% |
| Boxer Capital, LLC | 2,500,000 | $18,175 | 0.89% |
| Deep Track Capital, LP | 2,345,073 | $17,048,681 | 0.70% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 198,477 | $1,442,928 | 0.60% |